Clinical Trial: Neoadjuvant Chemotherapy in Advanced Epithelial Ovarian Cancer (EOC): A Phase III Randomized Study
Study Status: Active, not recruiting
Recruit Status: Unknown status
Study Type: Interventional
Official Title: Neoadjuvant Chemotherapy (NACT) Followed by Interval Debulking Surgery vs Upfront Surgery Followed by Chemotherapy (CT) in Advanced Epithelial Ovarian Carcinoma (EOC): A P
Brief Summary: To determine the impact of Neoadjuvant chemotherapy on surgical debulking rate, overall and disease-free survival and quality of life (QOL) in patients with advanced EOC.
Detailed Summary:
Sponsor: All India Institute of Medical Sciences, New Delhi
Current Primary Outcome: to compare the optimal debulking rate in primary surgery group and neoadjuvant chemotherapy group [ Time Frame: post surgery ]
Original Primary Outcome: Same as current
Current Secondary Outcome: post operative morbidity [ Time Frame: 3 weeks post op ]
Original Secondary Outcome: Same as current
Information By: All India Institute of Medical Sciences, New Delhi
Dates:
Date Received: July 14, 2008
Date Started: November 2001
Date Completion: June 2009
Last Updated: July 14, 2008
Last Verified: July 2008